🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Vitamin K antagonists (VKAs)

Found 12 matching trials

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

PHASE3

This program is a comprehensive evaluation of rheumatic valvular heart dise...

Status

Completed

Location

Princess Marina Hospital

Start Date

2016-08-22

Trial ID

NCT02832544

Treatments Being Tested

Rivaroxaban (20 mg)Vitamin K antagonists (VKA)

The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation

N/A

Background: Elastin is a unique protein providing elasticity, resilience an...

Status

Unknown

Location

Canisius Wilhelmina Hospital

Start Date

2017-10-31

Trial ID

NCT03285100

Treatments Being Tested

Venipuncture

Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine

N/A

Despite the rise in prescriptions for direct oral anticoagulants,Vitamin K ...

Status

Completed

Location

Uhmontpellier

Start Date

2017-07-01

Trial ID

NCT03914053

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

N/A

The multicenter registry will collect clinical data from 1600 patients with...

Status

Completed

Location

Krankenhaus St. Josef Braunau

Start Date

2016-04

Trial ID

NCT02663076

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

N/A

The main objective of this project is to evaluate savings in direct costs a...

Status

Completed

Location

Multiple Locations

Start Date

2015-06-01

Trial ID

NCT03462446

Treatments Being Tested

Rivaroxaban (Xarelto, BAY59-7939)Vitamin K antagonists (VKAs)

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

N/A

By evaluating routine clinical practice data from the UK primary care datab...

Status

Completed

Location

Many locations

Start Date

2020-05-01

Trial ID

NCT04297072

Treatments Being Tested

Rivaroxaban (Xarelto, BAY-597939)VKAs

Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

The purpose of this pilot study is to collect data on pregnancies with mech...

Status

Recruiting

Location

Mount Sinai Hospital

Start Date

2026-05-26

Trial ID

NCT07658989

Treatments Being Tested

LMWH and LDA Vitamin K antagonists (e.g warfarin)+/- LDA Sequential therapy +/- LDA

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

N/A

According to recent guidelines, long-term anticoagulation is recommended fo...

Status

Completed

Location

Multiple Locations

Start Date

2014-01

Trial ID

NCT02090543

Treatments Being Tested

Phenprocoumon (Marcumar)Rivaroxaban (Xarelto, BAY-59 7939)

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

N/A

This is an observational study in which only data are collected from partic...

Status

Not Yet Recruiting

Location

Many locations

Start Date

2026-09-01

Trial ID

NCT05900388

Treatments Being Tested

Rivaroxaban (Xarelto, BAY59-7939)Standard of care (SOC)

New Oral Anticoagulants (NOAC) in Stroke Patients

N/A

Registry to explore characteristics, use and management of new oral anticoa...

Status

Completed

Location

Felix Platter Spital

Start Date

2013-03-01

Trial ID

NCT03826927

Treatments Being Tested

treatment with NOACs or VKAs

Previous Next